MARLEE FRANKEL: Open Payments
NPI 1255787198 · BERLIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 16 payments from 10 companies in 2025. Trend: 2023 $515 · 2024 $271 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $88 |
| ABBVIE INC. | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Exact Sciences Corporation | 1 | $21 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
| ModernaTX, Inc. | 1 | $17 |
| Janssen Biotech, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: REXULTI, UBRELVY, AIRSUPRA, Cologuard Collection Kit, TZIELD, CREON, mResvia, TREMFYA.
Industry payments across NJ — which companies pay providers there.
